Standard BioTools to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Standard BioTools (NASDAQ: LAB) has announced its participation in three major investor conferences in March 2025. The company will present at TD Cowen's 45th Annual Healthcare Conference on March 3rd at 3:10 p.m. ET, attend investor meetings at the 2025 Leerink Partners Global Healthcare Conference on March 12th, and present at KeyBanc's 5th Annual Healthcare Forum on March 19th at 4:30 p.m. ET.

All presentations will be available via webcast on the company's Investor Relations website, with recordings archived at investors.standardbio.com.

News Market Reaction – LAB

+1.91%

1 alert

+1.91% News Effect

On the day this news was published, LAB gained 1.91%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SOUTH SAN FRANCISCO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that company management will participate in the following investor conferences:

• TD Cowen’s 45th Annual Healthcare Conference - March 3^rd – 5^th, 2025
  Presenting on Monday, March 3, 2025, at 3:10 p.m. ET
• 2025 Leerink Partners Global Healthcare Conference - March 9^th – 12^th, 2025
  Participating in investor meetings on March 12^th
• KeyBanc’s 5th Annual Healthcare Forum – March 18^th & 19^th, 2025
  Presenting on Wednesday, March 19, 2025, at 4:30 p.m. ET
  

Presentations will be webcast live and available on the Investor Relations page of the Company’s website at Events & Presentations. A recording will be archived and available on the Standard BioTools Investor Relations page at investors.standardbio.com.

About Standard BioTools Inc.

Standard BioTools Inc. (Nasdaq: LAB), has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary SomaScan, mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology and immunotherapy. Learn more at standardbio.com or connect with us on X, Facebook®, LinkedIn, and YouTube™.

For Research Use Only. Not for use in diagnostic procedures.

Limited Use Label License and other terms may apply: standardbio.com/legal/salesterms.
Patent and License Information: standardbio.com/legal/notices.
Trademarks: standardbio.com/legal/trademarks. Any other trademarks are the sole property of their respective owners. ©2025 Standard BioTools Inc. (f.k.a. Fluidigm Corporation). All rights reserved.

Investor Contact

David Holmes
ir@standardbio.com

FAQ

When is Standard BioTools (LAB) presenting at TD Cowen's Healthcare Conference in March 2025?

Standard BioTools will present at TD Cowen's Healthcare Conference on Monday, March 3, 2025, at 3:10 p.m. ET.

Which investor conferences will Standard BioTools (LAB) attend in March 2025?

Standard BioTools will attend TD Cowen's Healthcare Conference (March 3-5), Leerink Partners Global Healthcare Conference (March 9-12), and KeyBanc's Healthcare Forum (March 18-19).

How can investors access Standard BioTools (LAB) conference presentations?

Investors can access live webcasts and recordings of the presentations through the Events & Presentations section on Standard BioTools' Investor Relations website at investors.standardbio.com.

What is Standard BioTools' (LAB) schedule for the Leerink Partners Conference 2025?

Standard BioTools will participate in investor meetings at the Leerink Partners Global Healthcare Conference on March 12th, 2025.